Influenza and pneumococcal vaccination in patients with COPD

N. Roche (Paris, France), B. Aguilaniu (Grenoble, France), P. Burgel (Paris, France), M. Zysman (Bordeaux, France), D. Hess (Grenoble, France), E. Ouaalaya (Bordeaux, France), T. Tran (Paris, France), C. Raherison (Bordeaux, France)

Source: Virtual Congress 2020 – Pharmacological management of COPD
Session: Pharmacological management of COPD
Session type: E-poster session
Number: 2415
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Roche (Paris, France), B. Aguilaniu (Grenoble, France), P. Burgel (Paris, France), M. Zysman (Bordeaux, France), D. Hess (Grenoble, France), E. Ouaalaya (Bordeaux, France), T. Tran (Paris, France), C. Raherison (Bordeaux, France). Influenza and pneumococcal vaccination in patients with COPD. 2415

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007


Influenza vaccination in COPD
Source: International Congress 2019 – Vaccines against respiratory infections
Year: 2019


Perception and uptake of the influenza and pneumococcal vaccinations in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008

Influenza and pneumococcal vaccination
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017


Pneumococcal and influenza vaccination
Source: Eur Respir Monogr 2014; 63: 266-284
Year: 2014


Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004



The importance of pneumococcal and influenza vaccines in patients with allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 376s
Year: 2005

Indication of pneumococcal vaccination in CF patients
Source: Eur Respir J 2001; 18: Suppl. 33, 539s
Year: 2001

Impact of influenza vaccination in patients with CAP
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13)
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016


The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012



Compliance with the pneumococcal and influenza vaccination recommendations in patients with COPD in Catalonia (Spain)
Source: Eur Respir J 2005; 26: Suppl. 49, 594s
Year: 2005

Influenza vaccination and its relation with LRTI
Source: Annual Congress 2009 - PG1 EU GRACE Network Full-day Course: vaccination and preventive measures for LRTIs in the community: what’s new?
Year: 2009



Pneumococcal polysaccharide vaccination in COPD patients - some problems with antibody-response
Source: Eur Respir J 2002; 20: Suppl. 38, 472s
Year: 2002

Influenza and pneumoccocal vaccination protect against all cause mortality in COPD
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008

Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Pneumococcal vaccine in steroid-dependent COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005